Search research articles
Contact Us
Filters
Showing results (21-30 of 157) with videos related to
Page
of 16
Sort By:
The Biochemical Journal
|
April 1, 1985
Monoclonal antibodies recognizing epitopes carried on both glycolipids and glycoproteins of the human milk fat globule membrane
R A McIlhinney, S Patel, M E Gore
Cancer Treatment Reviews
|
November 2, 1999
New approaches to the systemic treatment of melanoma
S Chowdhury, M M Vaughan, M E Gore
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 11, 2004
Bilateral palmar contractures as a paraneoplastic syndrome in primary peritoneal carcinoma
K E Sleeman, M Harries, M E Gore
The New England Journal of Medicine
|
January 14, 1993
Tamoxifen and chemotherapy for refractory metastatic malignant melanoma
M J McKeage, A Lorentzos, M E Gore
European Journal of Immunology
|
April 1, 1984
A monoclonal antibody which differentiates between bound and free human secretory component
M E Gore, H J Bunnage, R A McIlhinney
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer
P Savage, D Costelna, J Moore, et al.
British Journal of Cancer
|
December 1, 1983
Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies
M E Gore, R A Skilton, R C Coombes
Seminars in Oncology
|
February 1, 1997
Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancer
M Hill, V Macfarlane, J Moore, et al.
Seminars in Oncology
|
February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?
A H Calvert, D R Newell, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinoma
P D Nathan, M E Gore, T G Eisen
Page
of 16
Search research articles
Search
Showing results (21-30 of 157) with videos related to
Sort By:
Page
of 16
The Biochemical Journal
|
April 1, 1985
Monoclonal antibodies recognizing epitopes carried on both glycolipids and glycoproteins of the human milk fat globule membrane
R A McIlhinney, S Patel, M E Gore
Cancer Treatment Reviews
|
November 2, 1999
New approaches to the systemic treatment of melanoma
S Chowdhury, M M Vaughan, M E Gore
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 11, 2004
Bilateral palmar contractures as a paraneoplastic syndrome in primary peritoneal carcinoma
K E Sleeman, M Harries, M E Gore
The New England Journal of Medicine
|
January 14, 1993
Tamoxifen and chemotherapy for refractory metastatic malignant melanoma
M J McKeage, A Lorentzos, M E Gore
European Journal of Immunology
|
April 1, 1984
A monoclonal antibody which differentiates between bound and free human secretory component
M E Gore, H J Bunnage, R A McIlhinney
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 1997
A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer
P Savage, D Costelna, J Moore, et al.
British Journal of Cancer
|
December 1, 1983
Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies
M E Gore, R A Skilton, R C Coombes
Seminars in Oncology
|
February 1, 1997
Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancer
M Hill, V Macfarlane, J Moore, et al.
Seminars in Oncology
|
February 1, 1992
Future directions with carboplatin: can therapeutic monitoring, high-dose administration, and hematologic support with growth factors expand the spectrum compared with cisplatin?
A H Calvert, D R Newell, M E Gore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Unexpected toxicity of combination thalidomide and interferon alpha-2a treatment in metastatic renal cell carcinoma
P D Nathan, M E Gore, T G Eisen
Page
of 16